Welcome to our dedicated page for Turtle Beach SEC filings (Ticker: TBCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Turtle Beach Corporation (NASDAQ: TBCH) filings with the U.S. Securities and Exchange Commission. Turtle Beach is a Nevada-incorporated gaming accessories company in the consumer electronics and technology sector, and its SEC reports offer detailed insight into its financial condition, capital structure, and governance.
Among the most relevant documents for TBCH are its current reports on Form 8-K. Recent 8-K filings disclose quarterly earnings press releases, including net revenue, gross profit, net income or loss, and the company’s use of non-GAAP measures such as Adjusted EBITDA. These filings also describe how management defines Adjusted EBITDA and why it is used alongside GAAP results.
Other 8-K reports detail material definitive agreements and financing arrangements, such as the senior secured credit agreement with Bank of America that provides a term loan and revolving credit facility. These filings outline key terms including maturity, collateral, interest rate structures, financial covenants, and permitted uses of proceeds, as well as the refinancing of prior debt arrangements.
Filings also cover equity and governance matters, including stock purchase agreements for share repurchases from existing shareholders, the adoption of a limited duration stockholder rights plan, and board changes such as director resignations. These documents explain how transactions were approved, including the role of independent directors and audit committee review, and describe the structure and purpose of the rights plan.
On Stock Titan, AI-powered tools can summarize lengthy Turtle Beach filings, highlight key terms in credit agreements, and clarify the implications of non-GAAP metrics and rights plans. Users can quickly locate earnings-related reports, financing disclosures, and governance updates, while also tracking how these regulatory documents relate to TBCH’s broader gaming accessories business.
Andrew Wolfe reports proposed resale of restricted common stock. The filing lists 2,500 restricted shares to be sold (date of grant 04/11/2019) and discloses recent open-market sales of 5,193 shares on 06/03/2026 and 11,076 shares on 06/09/2026. The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services.
TBCH reported an intended resale of 3,000 shares of Restricted Common Stock under Rule 144. The filing names Katherine Scherping as the selling holder and lists multiple prior transactions in the past three months, including large dispositions on 03/23/2026 and 05/27/2026.
Andrew Wolfe reported a sale of 5,193 shares of Common Stock on 06/03/2026 under a Form 144 submission. The filing shows cash proceeds of $67,606.11. The report also lists prior restricted stock grants dated 04/01/2024 (4,088 shares) and 04/01/2025 (6,988 shares).
Turtle Beach Corporation reported voting results from its 2026 Annual Meeting of Stockholders held by live webcast. Stockholders elected six directors to the Board, with support for nominees generally around 8.0–8.3 million votes in favor and approximately 0.28–0.89 million votes against, plus broker non-votes.
Stockholders ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 12,380,259 votes for, 207,376 against, and 8,381 abstentions. They also approved, on a non-binding advisory basis, the compensation of named executive officers, with 8,469,269 votes for, 172,584 against, 14,466 abstentions, and 3,939,697 broker non-votes.
Turtle Beach Corp director Katherine Lee Scherping reported open-market sales of 8,845 shares of common stock. She sold 1,845 shares on May 27, 2026 at an average price of $12.82 per share and additional blocks of 5,000 shares at $13.20 and 2,000 shares at $13.25. After these transactions, she directly holds 22,254 shares of Turtle Beach common stock.
TBCH affiliate filed a Form 144 proposing the sale of 2,000 shares of Common Stock (restricted stock) dated 04/01/2026. The filing lists prior dispositions by Katherine Scherping: 6,845 shares on 05/27/2026 for $89,659.91, 19,902 shares on 03/23/2026 for $231,221.44, and 98 shares on 03/20/2026 for $1,127.00. The excerpt also shows 19,847,421 shares outstanding as of 05/29/2026 in the header.
Turtle Beach Corporation reports an amendment to a Schedule 13G/A showing Albert Rabil beneficially owns 1,435,000 shares of Common Stock. The filing states this represents 7.23% of the class and that Mr. Rabil has sole voting and dispositive power over those shares as of 05/28/2026.
Treasury BioClinic Holdings (TBCH) reported proposed sales of restricted common stock via a Form 144 notice. The filing lists two restricted-stock lots dated 04/01/2025 for 1,845 shares and 04/01/2026 for 5,000 shares. It also records recent reported dispositions by Katherine Scherping of 19,902 shares on 03/23/2026 for $231,221.44 and 98 shares on 03/20/2026 for $1,127.00.
Turtle Beach Corporation announced a planned CFO transition and reaffirmed its full year 2026 financial guidance. Mark Weinswig intends to resign as Chief Financial Officer effective June 15, 2026, and will remain with the company until then to support a smooth handover.
Andrew Clipsham, currently Senior Finance Director for EMEA & ANZ, will become interim Chief Financial Officer and serve as principal financial and accounting officer. The company reiterated 2026 guidance for net revenue between $335 million and $355 million and Adjusted EBITDA between $44 million and $48 million, indicating its strategic and financial plans remain on track despite the leadership change.